The diagnosis of Cushing's syndrome: A typical presentations and laboratory shortcomings

Archives of Internal Medicine

Volumn 160, Issue 20, 2000, Pages 3045-3053

  Boscaro, M ^a   Barzon, L ^a   Sonino, N ^a  

^a UNIVERSITY OF PADOVA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; BARBITURIC ACID DERIVATIVE; CORTICOTROPIN; ESTROGEN; GLUCOCORTICOID; GLYCYRRHETINIC ACID; MIFEPRISTONE; PHENYTOIN; RIFAMPICIN;

ADRENAL CORTEX ADENOMA; CLINICAL FEATURE; CUSHING SYNDROME; DIAGNOSTIC ACCURACY; DIAGNOSTIC APPROACH ROUTE; DIAGNOSTIC ERROR; DIFFERENTIAL DIAGNOSIS; GOOD CLINICAL PRACTICE; HUMAN; HYPERALDOSTERONISM; HYPERCORTISOLISM; LABORATORY TEST; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; STEROID THERAPY; SYMPTOM;

EID: 0034645412     PISSN: 00039926     EISSN: None     Source Type: Journal    
DOI: 10.1001/archinte.160.20.3045     Document Type: Review

References (100)

1. The adrenal cortex
2. Diagnosis and management of Cushing's syndrome
3. Cushing's disease: 18 Years' experience
4. Cushing's syndrome: Killing disease: Discriminatory value of signs and symptoms aiding early diagnosis
5. Cushing's syndrome: A review of diagnostic tests
6. Cushing's syndrome: Update of diagnosis and management
7. The Cushing's syndrome: An update on diagnostic tests
8. Cushing's syndrome
9. The role of the laboratory in the diagnosis of Cushing's syndrome
10. Clinical and biochemical evaluation of Cushing's syndrome
11. Endocrine investigation: Cushing's syndrome
12. Diagnosis and management of Cushing's syndrome: Results of an Italian multicentric study
13. Direct measurement of the precursors of adrenocorticotropin in human plasma by two-site immunoradiometric assay
14. Analysis of peptide hormones of the hypothalamic pituitary adrenal axis using 'two-site' immunoradiometric assays
15. Familial Cushing's syndrome due to primary pigmented nodular adrenocortical disease
16. Gastric inhibitory polypeptide-dependent cortisol hypersecretion: A new cause of Cushing's syndrome
17. Food dependent Cushing's syndrome mediated by aberrant adrenal sensitivity to gastric inhibitory polypeptide
18. Adrenal scintigraphy in the morphological and functional evaluation of Cushing's syndrome
19. Petrosal sinus sampling with and without corticotropin-releasing hormone for the differential diagnosis of Cushing's syndrome
20. Value of computed tomography of the abdomen and chest in investigations of Cushing's syndrome
21. The accuracy of CT and MR evaluation of the sella turcica for detection of adrenocorticotropic hormone-secreting adenomas in Cushing's disease
22. MR of corticotropin-secreting pituitary microadenomas
23. Dctreotide and ectopic Cushing's syndrome: A commentary
24. Tumor localization: The ectopic ACTH syndrome
25. Cushing's disease with periodic hormonogenesis: One explanation for paradoxical response to dexamethasone
26. Five cases of cyclical Cushing's syndrome
27. Cyclic Cushing's syndrome combined with cortisol suppressible, dexamethasone non-suppressible ACTH secretion: A new variant of Cushing's syndrome
28. Cyclical Cushing's syndrome presenting as short stature in a boy with recurrent atrial myxomas and freckled skin pigmentation
29. Cushing's disease with intermittent hypercortisolism
30. Diagnostic difficulties in periodic Cushing's syndrome
31. Evidence for ectopic ACTH production years after bilateral adrenalectomy for Cushing's syndrome
32. Perils and pitfalls in the diagnosis of Cushing's syndrome
33. The pituitary 'incidentaloma'
34. Pituitary magnetic resonance imaging in normal human volunteers: Occult adenomas in the general population
35. PET in oncology: Will it replace the other modalities?
36. Incidentally discovered adrenal masses
37. Incidentally discovered adrenal tumors: Endocrine and scintigraphic correlates
38. Unilateral adrenal hypertrophy in ectopic ACTH syndrome
39. Transition from pituitary-dependent to adrenal-dependent Cushing's syndrome
40. Hypercortisolism with non-pigmented micronodular adrenal hyperplasia: Transition from pituitary-dependent to adrenal-dependent Cushing's syndrome
41. Pituitary ACTH dependency of nodular adrenal hyperplasia in Cushing's syndrome: Report of two cases and review of the literature
42. Immunoglobulins of patients with Cushing's syndrome due to pigmented adrenocortical micronodular dysplasia stimulate in vivo steroidogenesis
43. Familial Cushing's syndrome due to nodular adrenocortical dysplasia is an inherited disease of immunological origin
44. Primary pigmented nodular adrenocortical disease: Reevaluation of a patient with Carney complex 27 years after unilateral adrenalectomy
45. A patient with hypocortisolism and Cushing's syndrome-like manifestations: Cortisol hyperreactive syndrome
46. Normocortisolemic Cushing's syndrome initially presenting with increase glucocorticoid receptor numbers
47. Factitious Cushing's syndrome
48. Cushing's syndrome associated with pheochromocytoma
49. Evolving concepts in the pathophysiology, diagnosis, and treatment of pheochromocytoma
50. Cushing's syndrome in children and adolescents
51. Cushing's syndrome and pregnancy: Aetiologies and prognosis in twenty-two patients
52. Cushing's syndrome in pregnancy
53. Placental corticotropin-releasing hormone may be a stimulator of maternal pituitary adrenocorticotrophic hormone secretion in humans
54. Cushing's syndrome in pregnancy secondary to adrenal adenoma: A case report and literature review
55. Diagnosis and selective cure of Cushing's disease during pregnancy by transsphenoidal surgery
56. A comparison of adrenal cortical function in patients with depressive illness and Cushing's disease
57. Neuroendocrinology and psychiatric illness
58. Urinary free cortisol excretion in depression
59. Serotonin, Cushing's disease, and depression
60. Responses to corticotropin-releasing hormone in the hypercortisolism of depression and Cushing's disease
61. On the mechanism of alcohol-induced pseudo-Cushing's syndrome
62. Syndromes of glucocorticoid resistance
63. Glucocorticoid resistant syndromes: Molecular basis and clinical presentations
64. Metabolic, endocrine, and drug induced interference with pituitary function tests: A review
65. Abnormal hypothalamic-pituitary-adrenal function in anorexia nervosa
66. Stress and the hypothalamo-pituitary adrenal axis
67. Cushing's syndrome: An evaluation of the clinical usefulness of urinary free cortisol and other urinary steroid measurements in diagnosis
68. A single sleeping midnight cortisol has 100% sensitivity for the diagnosis of Cushing's syndrome
69. A single midnight serum cortisol measurement distinguishes Cushing's syndrome from pseudo-Cushing's states
70. Differential diagnosis and management of Cushing's syndrome
71. The dexamethasone-suppressed corticotropin-releasing hormone stimulation test differentiates mild Cushing's disease from normal physiology
72. Tests of pituitary-adrenal suppressibility in the diagnosis of Cushing's disease
73. Urine free cortisol in the high-dose dexamethasone suppression test for the differential diagnosis of the Cushing's syndrome
74. A comparison of the standard high dose dexamethasone suppression test and the overnight 8-mg dexamethasone suppression test for the differential diagnosis of adrenocorticotropin-dependent Cushing's syndrome
75. Effectiveness versus efficacy: The limited value in clinical practice of high dose dexamethasone suppression testing in the differential diagnosis of adrenocorticotropin-dependent Cushing's syndrome
76. Diagnosis and management of ectopic ACTH-dependent Cushing's syndrome: Comparison of the features in ectopic and pituitary ACTH production
77. A very high dose dexamethasone suppression test for differential diagnosis of Cushing's syndrome
78. Immunoradiometric assay of succinylated corticotropin: An improved method for quantification of ACTH
79. Clinical applications of corticotropin-releasing-factor
80. A simplified morning ovine corticotropin-releasing hormone stimulation test for differential diagnosis of adrenocorticotropin-dependent Cushing's syndrome
81. Ectopic ACTH syndrome caused by a bronchial carcinoid tumor responsive to dexamethasone, metyrapone, and corticotropin-releasing factor
82. Corticotropin-releasing hormone testing in pituitary disease
83. Routine inferior petrosal sinus sampling in the differential diagnosis of adrenocorticotropin (ACTH)-dependent Cushing's syndrome: Early recognition of the occult ectopic ACTH syndrome
84. Selective venous sampling in the differential diagnosis of ACTH-dependent Cushing's syndrome
85. A critical analysis of the value of simultaneous inferior petrosal sampling in Cushing's disease and the occult ectopic adrenocorticotropin syndrome
86. Biochemical and radiologic diagnosis of Cushing's syndrome
87. The hypoplastic inferior petrosal sinus: A potential source of false-negative results in petrosal sampling for Cushing's disease
88. Petrosal sinus sampling for diagnosis of Cushing's disease: Evidence of false negative results
89. Venous angiography is needed to interpret inferior petrosal sinus and cavernous sinus sampling data for lateralizing adrenocorticotropin-secreting adenomas
90. Cushing's syndrome from an ectopic pituitary adenoma with peliosis: A histological, immunohistochemical and ultrastructural study and review of the literature
91. Improved diagnostic accuracy of inferior petrosal sinus sampling over imaging for localizing pituitary pathology in patients with Cushing's disease
92. The limited ability of inferior petrosal sinus sampling with corticotropin-releasing hormone to distinguish Cushing's disease from pseudo-Cushing's states or normal physiology
93. Inferior petrosal sinus sampling in healthy human subjects reveals a unilateral corticotropin-releasing hormone-induced arginine vasopressin release associated with ipsilateral adrenocorticotropin secretion
94. Neurologic complications of petrosal sinus sampling
95. Human corticosteroid binding globulin
96. Studies on dexamethasone metabolism in man: Effect of diphenylhydantoin
97. Metabolism of 2 and 6β-hydroxycortisol in man. Determination of production rates of 6β-hydroxycortisol with and without phenobarbital administration
98. Pharmacokinetics of aldosterone in patients with Addison's disease: Effect of rifampicin treatment on glucocorticoid and mineralcorticoid metabolism
99. Syndrome of apparent mineralocorticoid excess: A defect in the cortisolcortisone shuttle
100. The influence of glycyrrhetinic acid on plasma cortisol and cortisone in healthy young volunteers